Evidence map›Paper›PMID 25170119›Full record

ArticleJournal of lipid research2014

Ketogenic diet sensitizes glucose control of hippocampal excitability.

Masahito Kawamura, David N Ruskin, Jonathan D Geiger, Detlev Boison, Susan A Masino

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Adenosine Kinase: An Epigenetic Modulator and Drug Target.Journal of inherited metabolic disease · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Adenosine and Ketogenic Treatments.Journal of caffeine and adenosine research · 2020
    Review
  12. Review
  13. Adenosine AJournal of neurophysiology · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The Antiepileptic Ketogenic Diet Alters Hippocampal Transporter Levels and Reduces Adiposity in Aged Rats.The journals of gerontology. Series A, Biological sciences and medical sciences · 2018
    Article
  20. Electrical Control in Neurons by the Ketogenic Diet.Frontiers in cellular neuroscience · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Masahito KawamuraDepartment of Pharmacology, Jikei University School of Medicine, Minato-ku, Tokyo 105-8461, Japan.
David N RuskinPsychology Department and Neuroscience Program, Trinity College, Hartford, CT 06106.
Jonathan D GeigerDepartment of Basic Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58203.
Detlev BoisonRobert Stone Dow Neurobiology Laboratories, Legacy Research Institute, Portland, OR 97232.
Susan A MasinoPsychology Department and Neuroscience Program, Trinity College, Hartford, CT 06106.
Hartford Financial Services (United States)Jikei University School of Medicine · JPLegacy Health · USTrinity College · USUniversity of North Dakota · US

Funding

Pilot Projects CoreP30GM103329 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI GEIGER, JONATHAN DAVID · 2012 to 2016
$5.1M
The Role of Adenosine in Ketogenic Diet TherapyR01NS065957 · NINDS · TRINITY COLLEGE · PI BOISON, DETLEV, GEIGER, JONATHAN DAVID · 2010 to 2021
$3.9M
Astrocyte dysfunction in epileptogenesis: the role of adenosineR01NS061844 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2009 to 2013
$1.5M
Ketogentic diet-induced changes in the cerebrospinal fluid: biomarkers and mechanismsR15NS066392 · NINDS · TRINITY COLLEGE · PI MASINO, SUSAN A · 2010 to 2015
$583k
Neuronal endolysosome involvement in HIV-1 Tat-induced amyloid beta accumulationR21AG043338 · NIA · UNIVERSITY OF NORTH DAKOTA · PI CHEN, XUESONG, GEIGER, JONATHAN DAVID · 2012 to 2013
$336k
NIA NIH HHS AG043338NIA NIH HHS R21 AG043338NIGMS NIH HHS GM103329NIGMS NIH HHS P30 GM103329NINDS NIH HHS NS061844NINDS NIH HHS NS065957NINDS NIH HHS NS066392NINDS NIH HHS R01 NS061844NINDS NIH HHS R01 NS065957NINDS NIH HHS R15 NS066392
6 · The paper itself

Abstract

A high-fat low-carbohydrate ketogenic diet (KD) is an effective treatment for refractory epilepsy, yet myriad metabolic effects in vivo have not been reconciled clearly with neuronal effects. A KD limits blood glucose and produces ketone bodies from β-oxidation of lipids. Studies have explored changes in ketone bodies and/or glucose in the effects of the KD, and glucose is increasingly implicated in neurological conditions. To examine the interaction between altered glucose and the neural effects of a KD, we fed rats and mice a KD and restricted glucose in vitro while examining the seizure-prone CA3 region of acute hippocampal slices. Slices from KD-fed animals were sensitive to small physiological changes in glucose, and showed reduced excitability and seizure propensity. Similar to clinical observations, reduced excitability depended on maintaining reduced glucose. Enhanced glucose sensitivity and reduced excitability were absent in slices obtained from KD-fed mice lacking adenosine A1 receptors (A1Rs); in slices from normal animals effects of the KD could be reversed with blockers of pannexin-1 channels, A1Rs, or KATP channels. Overall, these studies reveal that a KD sensitizes glucose-based regulation of excitability via purinergic mechanisms in the hippocampus and thus link key metabolic and direct neural effects of the KD.

Indexed as

Diet, KetogenicAnimalsCA3 Region, HippocampalConnexinsFemaleGene Knockout TechniquesGlucoseHippocampusKATP ChannelsMaleMiceNerve Tissue ProteinsRatsReceptor, Adenosine A1SeizuresConnexinsGlucoseKATP ChannelsNerve Tissue ProteinsPanx1 protein, mouseReceptor, Adenosine A18-cyclopentyl-1,3-dipropylxanthineadenosine A1 receptorsbicucullineepilepsyKATP channelketonesmetabolismpannexinpurineseizure

Identifiers

PMID25170119
PMCPMC4617128
OpenAlexW2167750958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.